Benazepril

In some countries, this medicine may only be approved for veterinary use.

In the US, Benazepril (benazepril systemic) is a member of the drug class angiotensin converting enzyme inhibitors and is used to treat Diabetic Kidney Disease, Heart Failure, High Blood Pressure and Left Ventricular Dysfunction.

US matches:

• Benazepril


• Benazepril/Hydrochlorothiazide


• Benazepril and hydrochlorothiazide


• Benazepril Hydrochloride


• Benazepril Hydrochloride/Hydrochlorothiazide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C09AA07

CAS registry number (Chemical Abstracts Service)

0086541-75-5

Chemical Formula

C24-H28-N2-O5

Molecular Weight

424

Therapeutic Category

ACE inhibitor

Chemical Name

1H-1-Benzazepine-1-acetic acid, 3-[[1-(ethoxycarbonyl)-3-phenylpropyl]-amino]-2,3,4,5-tetrahydro-2-oxo-, [S-(R*,R*)]-

Foreign Names

• Benazeprilum (Latin)
• Benazepril (German)
• Bénazépril (French)
• Benazepril (Spanish)

Generic Names

• Benazepril (OS: DCIT, JAN, BAN)
• Bénazépril (OS: DCF)
• Benazepril Hydrochloride (OS: BANM, USAN)
• CGS 14824 A (IS: Ciba)
• Benazepril Hydrochloride (PH: Ph. Eur. 6, USP 32, BP 2010)

Brand Names

• Benazepril Sandoz
  Hexal, Romania



• Benazepril
  Teva, Israel



• Lotensin HCT (Benazepril and Hydrochlorothiazide)
  Meda, Hungary



• Amlodipine Besylate and Benazepril Hydrochloride (Benazepril and Amlodipine besilate)
  Lupin, United States; Teva USA, United States



• Apo-Benazepril
  Apotex, Canada



• Benace
  Novartis, India



• Benakor
  Gräub, Switzerland



• Benakor (veterinary use)
  Virbac, France



• Benazecare (veterinary use)
  Animalcare Ltd., Luxembourg



• Benazep
  Sawai Seiyaku, Japan



• Benazeplus AL (Benazepril and Hydrochlorothiazide)
  Aliud, Germany



• Benazeplus Stada (Benazepril and Hydrochlorothiazide)
  Stada, Germany



• Benazepril AL
  Aliud, Germany



• Benazepril beta comp (Benazepril and Hydrochlorothiazide)
  Betapharm, Germany



• Benazepril comp. Heumann (Benazepril and Hydrochlorothiazide)
  Heumann, Germany



• Bénazépril EG
  EG Labo, France



• Benazepril HCl
  Teva USA, United States



• Benazepril Heumann
  Heumann, Germany



• Benazepril Hexal
  Hexal, Germany



• Benazepril Hexal comp (Benazepril and Hydrochlorothiazide)
  Hexal, Germany



• Benazepril Hydrochloride and Hydrochlorothiazide (Benazepril and Hydrochlorothiazide)
  Andrx, United States; Genpharm, United States; Mylan, United States; Ranbaxy, United States; Sandoz, United States



• Benazepril Hydrochloride
  Andrx, United States; Apotex, United States; Aurobindo, United States; Biokey, United States; Genpharm, United States; KV Pharmaceutical, United States; Mylan, United States; Ranbaxy, United States; Sandoz, United States; Zydus, United States



• Bénazépril Hydrochlorothiazide EG (Benazepril and Hydrochlorothiazide)
  EG Labo, France



• Bénazépril Mylan
  Mylan, France



• Benazepril STADA
  Stada, Poland



• Benazepril Winthrop comp (Benazepril and Hydrochlorothiazide)
  Winthrop, Germany



• Benazepril with Hydrochlorothiazide (Benazepril and Hydrochlorothiazide)
  Andrx, United States; Eon, United States; Ranbaxy, United States; Sandoz, United States



• Benazepril-1A Pharma
  1A Pharma, Germany



• Benazepril-1A Pharma comp (Benazepril and Hydrochlorothiazide)
  1A Pharma, Germany



• Benazepril-Hexal
  Hexal, Luxembourg



• Boncordin
  Sandoz, Argentina



• Briazide (Benazepril and Hydrochlorothiazide)
  Pierre Fabre Médicament, France



• Briem
  Pierre Fabre Médicament, France



• Chlorowodorek benazeprilu LeVet (veterinary use)
  Produlab Pharma, Poland



• Cibace
  Novartis, South Africa



• Cibacen Cor
  Meda, Germany



• Cibacen
  Meda, Germany; Meda, Denmark; Meda, Ireland; Meda, Iceland; Meda, Italy; Meda, Luxembourg; Meda, Netherlands; Meda Pharm, Greece; Meda Pharma Sau, Spain; Novartis, Belgium; Novartis, Bulgaria; Novartis, Bahrain; Novartis, Switzerland; Novartis, Georgia; Novartis, Ghana; Novartis, Guyana; Novartis, Indonesia; Novartis, Israel; Novartis, Japan; Novartis, Kenya; Novartis, Malta; Novartis, Nigeria; Novartis, Philippines; Novartis, Romania; Novartis, Sudan; Novartis, Turkey; Novartis, Taiwan; Novartis, Tanzania; Novartis, Zimbabwe



• Cibacène
  Meda, France; Meda, France



• Cibadrex
  Novartis, Ghana; Novartis, Kenya; Novartis, Nigeria; Novartis, Sudan; Novartis, Tanzania; Novartis, Zimbabwe



• Cibadrex (Benazepril and Hydrochlorothiazide)
  Meda, Germany; Meda, France; Meda, Luxembourg; Meda Pharm, Greece; Meda Pharma Sau, Spain; Novartis, Bulgaria; Novartis, Bulgaria; Novartis, Bahrain; Novartis, Switzerland; Novartis, South Africa



• Fortekor (veterinary use)
  Novartis, Ireland; Novartis Animal Health, Austria; Novartis Animal Health, Belgium; Novartis Animal Health, United Kingdom; Novartis Animal Health, Italy; Novartis Animal Health, Luxembourg; Novartis Animal Health, Netherlands; Novartis Animal Health, Norway; Novartis Animal Health, New Zealand; Novartis Animal Health, Sweden; Novartis Animal Health, South Africa; Novartis Animal Health Australasia, Australia; Novartis Farma -Produtos Farmaceuticos S.A., Portugal; Novartis Santé Animale, France; Novartis Tiergesundheit, Switzerland; Novartis Tiergesundheit, Germany; Novartis vet., Finland



• Labodrex (Benazepril and Hydrochlorothiazide)
  Meda Pharma Sau, Spain



• Labopal
  Glaxo SmithKline, Spain



• Lisonid
  Actavis Group, Poland



• Lotensin HCT (Benazepril and Hydrochlorothiazide)
  Novartis, United States



• Lotensin
  Meda, Hungary; Novartis, Brazil; Novartis, Canada; Novartis, China; Novartis, Poland; Novartis, Russian Federation; Novartis, United States



• Lotrel (Benazepril and Amlodipine besilate)
  Novartis, United States



• Nelio (veterinary use)
  Sogeval, France



• Prebase
  Towa Yakuhin, Japan



• Tatsujipin
  Tatsumi Kagaku, Japan



• Tensanil
  Savio, Italy



• Zaprace-D (Benazepril and Hydrochlorothiazide)
  Ranbaxy, China



• Zinadril
  Errekappa, Italy

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Rasoltan

Rasoltan may be available in the countries listed below.

Ingredient matches for Rasoltan

Losartan

Losartan is reported as an ingredient of Rasoltan in the following countries:

• Georgia

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Rasoltan in the following countries:

• Bulgaria


• Hungary


• Poland

International Drug Name Search

Celebrex

Celebrex is a brand name of celecoxib, approved by the FDA in the following formulation(s):

CELEBREX (celecoxib - capsule; oral)

• 
  Manufacturer: GD SEARLE
  
  Approval date: December 31, 1998
  
  Strength(s): 100MG, 200MG
  


• 
  Manufacturer: GD SEARLE
  
  Approval date: August 29, 2002
  
  Strength(s): 400MG ^[RLD]


• 
  Manufacturer: GD SEARLE
  
  Approval date: December 15, 2006
  
  Strength(s): 50MG
  

Has a generic version of Celebrex been approved?

No. There is currently no therapeutically equivalent version of Celebrex available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Celebrex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Substituted pyrazolyl benzenesulfonamides
  Patent 5,466,823
  Issued: November 14, 1995
  Inventor(s): Talley; John J. & Penning; Thomas D. & Collins; Paul W. & Rogier, Jr.; Donald J. & Malecha; James W. & Miyashiro; Julie M. & Bertenshaw; Stephen R. & Khanna; Ish K. & Graneto; Matthew J. & Rogers; Roland S. & Carter; Jeffery S.
  Assignee(s): G.D. Searle & Co.
  A class of pyrazolyl benzenesulfonamide compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula I: ##STR1## or a pharmaceutically-acceptable salt thereof.
  
  Patent expiration dates:
  
  
  • November 30, 2013
    
    ✓ 
    Drug substance
  
  
  
  • May 30, 2014
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
  Patent 5,563,165
  Issued: October 8, 1996
  Inventor(s): Talley; John J. & Penning; Thomas D. & Collins; Paul W. & Rogier, Jr.; Donald J. & Malecha; James W. & Miyashiro; Julie M. & Bertenshaw; Stephen R. & Khanna; Ish K. & Graneto; Matthew J. & Rogers; Roland S. & Carter; Jeffery S.
  Assignee(s): G. D. Searl & Co.
  A class of pyrazolyl benzenesulfonamide compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula I: ##STR1##
  
  Patent expiration dates:
  
  
  • November 30, 2013
    
    ✓ 
    Drug product
  
  
  
  • May 30, 2014
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
  Patent 5,760,068
  Issued: June 2, 1998
  Inventor(s): Talley; John J. & Penning; Thomas D. & Collins; Paul W. & Rogier, Jr.; Donald J. & Malecha; James W. & Miyashiro; Julie M. & Bertenshaw; Stephen R. & Khanna; Ish K. & Graneto; Matthew J. & Rogers; Roland S. & Carter; Jeffery S. & Docter; Stephen H. & Yu; Stella S.
  Assignee(s): G.D. Searle & Co.
  A class of pyrazolyl benzenesulfonamide compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula II: ##STR1## or a pharmaceutically-acceptable salt thereof.
  
  Patent expiration dates:
  
  
  • June 2, 2015
    
    ✓ 
    Patent use: TREATMENT OF INFLAMMATION OR AN INFLAMMATION-ASSOCIATED DISORDER
  
  
  
  • December 2, 2015
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Celebrex Consumer Information (Drugs.com)
• Celebrex Consumer Information (Wolters Kluwer)
• Celebrex Consumer Information (Cerner Multum)
• Celebrex Advanced Consumer Information (Micromedex)
• Celebrex AHFS DI Monographs (ASHP)
• Celecoxib Consumer Information (Drugs.com)
• Celecoxib Consumer Information (Wolters Kluwer)
• Celecoxib Consumer Information (Cerner Multum)
• Celecoxib Advanced Consumer Information (Micromedex)
• Celecoxib AHFS DI Monographs (ASHP)

Acido Folico L.CH.

Acido Folico L.CH. may be available in the countries listed below.

Ingredient matches for Acido Folico L.CH.

Folic Acid

Folic Acid is reported as an ingredient of Acido Folico L.CH. in the following countries:

• Chile

International Drug Name Search

Atestad

Atestad may be available in the countries listed below.

Ingredient matches for Atestad

Atenolol

Atenolol is reported as an ingredient of Atestad in the following countries:

• Philippines

International Drug Name Search

Almiral

Almiral may be available in the countries listed below.

Ingredient matches for Almiral

Diclofenac

Diclofenac diethylamine (a derivative of Diclofenac) is reported as an ingredient of Almiral in the following countries:

• Slovakia

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Almiral in the following countries:

• Bahrain


• Bangladesh


• Bulgaria


• Czech Republic


• Estonia


• Ethiopia


• Hong Kong


• Iraq


• Jordan


• Latvia


• Malta


• Oman


• Romania


• Singapore


• Slovakia


• Sri Lanka


• Sudan


• Taiwan


• Yemen

International Drug Name Search

Pupilla

Pupilla may be available in the countries listed below.

Ingredient matches for Pupilla

Benzalkonium Chloride

Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Pupilla in the following countries:

• Italy

Naphazoline

Naphazoline nitrate (a derivative of Naphazoline) is reported as an ingredient of Pupilla in the following countries:

• Italy

International Drug Name Search